Oramed Pharmaceuticals Inc.
ORMP· Nasdaq
ORMPOramed Pharmaceuticals Inc.
Filed Jul 1, 2015 · 10-Q · 31 days after period end · 0001213900-15-004892
| Metric | Q3 2015 | Q3 2014 | Q3 2013 | Q3 2012 |
|---|---|---|---|---|
| Net Income | -$1.58M | $1.83M | -$1.26M | -$550.37K |
| EPS Diluted | $0.15 | $0.18 | $0.17 | $0.09 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oramed Pharmaceuticals Inc. · CIK 1176309 · Engraved from SEC EDGAR
ended May 31, 2015 · filed Jul 1, 2015 · 31 d after period end
